F-group (family)
1.1.5.6 Peptidase_S7
Ligands and drugs
177
Member domains
83
with ligand contacts (≤ 4 Å)
46.9% of members
49
with DrugDomain annotations
27.7% of members
16
with a DrugBank compound
9.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1.1.5.6 belongs to X-group 1 cradle loop barrel, which binds 9.4 ligand superclasses per 20 proteins, broader than 87% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03793 | BEZ | Benzoic acid | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 7 |
| BEZ | BENZOIC ACID | 4 |
| 7HS | (S)-2-acetamido-6-amino-N-((S)-5-guanidino-1-oxopentan-2-yl)hexanamide | 2 |
| A1CD1 | 2-(5-methylthiophen-2-yl)ethan-1-amine | 2 |
| A1CD2 | (1S,3S)-3-ethoxy-7-azaspiro[3.5]nonan-1-ol | 2 |
| A1CDT | N-(2-aminoethyl)thiophene-2-carboxamide | 2 |
| A1CDX | 2-[(1S)-2,2-difluorocyclopentyl]ethan-1-amine | 2 |
| A1H2Z | (1~{E})-1-[3-[(2~{R})-1-phenylpropan-2-yl]-2~{H}-1,2,3-oxadiazol-3-ium-5-ylidene]-3-[3-(trifluoromethyl)phenyl]urea | 2 |
| A1H3F | 1-[3-[[5-[4-[2-(dimethylamino)ethoxy]-6-methyl-pyrimidin-5-yl]pyridin-2-yl]methyl]-1,2,3-oxadiazol-3-ium-5-yl]-3-[3-(trifluoromethyl)phenyl]urea | 2 |
| A1I16 | 1-[3-[[5-(4,6-dimethylpyrimidin-5-yl)pyridin-2-yl]methyl]-1-oxa-2,3$l^{4}-diazacyclopenta-2,4-dien-5-yl]-3-[3-(trifluoromethyl)phenyl]urea | 2 |
| A1JF2 | 3-[[[(2~{R})-2-[2,4-bis(fluoranyl)phenyl]-2-oxidanyl-ethyl]amino]methyl]quinolin-2-ol | 2 |
| A1JF3 | ~{N}-[(2~{S})-2-(6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-yl)propyl]-5-methyl-furan-2-carboxamide | 2 |
| NKK | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide | 2 |
| WQY | 1-(quinolin-3-yl)methanamine | 2 |
| 3CF | 3-cyano-L-phenylalanine | 1 |
| 4CF | 4-cyano-L-phenylalanine | 1 |
| 7HQ | benzimidazol-1-ylmethanol | 1 |
| 7PZ | 1-[(5~{R},8~{R},15~{S},18~{S})-15,18-bis(4-azanylbutyl)-4,7,14,17,20-pentakis(oxidanylidene)-5-propan-2-yl-3,6,13,16,19-pentazabicyclo[20.3.1]hexacosa-1(25),22(26),23-trien-8-yl]guanidine | 1 |
| 7Q3 | 1-[(3~{S},6~{R},18~{R})-3,6-bis(4-azanylbutyl)-2,5,8,11,14,17-hexakis(oxidanylidene)-1,4,7,10,13,16-hexazacyclodocos-18-yl]guanidine | 1 |
| 7QG | 1-[(3~{S},6~{S},19~{R})-3,6-bis(4-azanylbutyl)-2,5,8,12,15,18-hexakis(oxidanylidene)-1,4,7,11,14,17-hexazacyclotricos-19-yl]guanidine | 1 |